Home Industry Reports Custom Research Blogs About Us Contact us

Corticosteroids Market Size & Share, By Product (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical, Injectable, Oral, Inhaled), Application (Skin Allergies, Rheumatology Indications), Distribution Channel, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Report ID: FBI 2920


Published Date: May-2024


Format : PDF, Excel

Market Outlook:

Corticosteroids Market size exceeded USD 5.36 Billion in 2023 and is set to cross USD 10.29 Billion by 2032, growing at over 7.8% CAGR between 2024 and 2032.

Base Year Value (2023)

USD 5.36 Billion

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)


19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 10.29 Billion

19-23 x.x %
24-32 x.x %
Corticosteroids Market

Historical Data Period


Corticosteroids Market

Largest Region

North America

Corticosteroids Market

Forecast Period


Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunity:

1. Increasing prevalence of chronic diseases: The demand for corticosteroids is likely to increase with the rising prevalence of chronic diseases such as asthma, rheumatoid arthritis, and chronic obstructive pulmonary disease (COPD). Corticosteroids are used in the treatment of these conditions to reduce inflammation and suppress the immune system, thereby driving the growth of the market.

2. Growing geriatric population: The elderly population is at a higher risk of developing age-related diseases and conditions that require corticosteroid therapy. As the global population continues to age, there will be a greater need for corticosteroid medications, driving the growth of the market.

3. Increasing awareness and acceptance of corticosteroid therapy: As the understanding of corticosteroids continues to evolve and expand, there is a growing acceptance and awareness of their therapeutic benefits. This is expected to drive the demand for corticosteroids in the market, as more healthcare professionals and patients recognize their efficacy in treating various conditions.

4. Technological advancements in drug delivery systems: The development of advanced drug delivery systems for corticosteroids, such as inhalers and biodegradable implants, is expected to drive market growth. These innovative delivery systems enhance the efficacy and safety of corticosteroid therapy, leading to increased adoption and market expansion.

Report Scope

Report CoverageDetails
Segments CoveredProduct, Route Of Administration, Application, Distribution Channel
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledAbbVie, Astellas Pharma, AstraZeneca plc, Bausch Health Companies, Bayer AG, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limited, Merck & Co., Novartis AG, Pfizer, Sanofi S.A

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

1. Adverse effects and safety concerns: The long-term use of corticosteroids is associated with a range of adverse effects, including osteoporosis, diabetes, and immune suppression. These safety concerns limit the widespread use of corticosteroids and may restrain market growth, particularly in the context of alternative treatment options.

2. Stringent regulatory requirements: The corticosteroids market is subject to strict regulatory oversight due to the potential for misuse and abuse of these medications. This can create barriers to market entry and hinder the development and commercialization of new corticosteroid therapies, thereby restraining market growth.

3. Availability of alternative treatment options: The availability of alternative treatment options, such as non-steroidal anti-inflammatory drugs (NSAIDs) and biologic therapies, may pose a restraint to the corticosteroids market. Patients and healthcare providers may opt for these alternatives due to their perceived safety and efficacy profiles, thereby limiting the growth potential of corticosteroids in the market.

Regional Forecast:

Corticosteroids Market

Largest Region

North America

USD 1.96 Billion in 2023

Get more details on this report -

North America:

The North American corticosteroids market, which includes the United States and Canada, is expected to witness significant growth due to the rising prevalence of chronic diseases such as asthma, arthritis, and allergies. Additionally, the increasing geriatric population and growing awareness about the benefits of corticosteroids are likely to contribute to the market's expansion in this region. Furthermore, the presence of key market players and ongoing research and development activities are expected to boost market growth in North America.

Asia Pacific:

In the Asia Pacific region, which includes countries like China, Japan, and South Korea, the corticosteroids market is anticipated to experience rapid growth due to the rising incidence of skin diseases, autoimmune disorders, and respiratory conditions. Increasing healthcare expenditure, technological advancements, and the growing adoption of corticosteroids for various therapeutic applications are further driving the market expansion in these countries. Additionally, the presence of a large patient pool and developing healthcare infrastructure are expected to fuel market growth in the Asia Pacific region.


In Europe, particularly in the United Kingdom, Germany, and France, the corticosteroids market is projected to witness steady growth owing to the increasing prevalence of chronic respiratory diseases and inflammatory conditions. The presence of established healthcare infrastructure, favorable government initiatives, and rising R&D activities are contributing to the market's expansion in this region. Moreover, the growing demand for advanced treatment options and the rising geriatric population are expected to further propel market growth in Europe.

Overall, the corticosteroids market in North America, Asia Pacific, and Europe is expected to witness substantial growth, driven by factors such as increasing disease prevalence, technological advancements, and growing healthcare expenditure. The presence of key market players and ongoing research and development activities are also anticipated to contribute to the market's expansion in these regions.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Corticosteroids Market
Corticosteroids Market

Segmentation Analysis:


In terms of segmentation, the global corticosteroids market is analyzed on the basis of Product, Route Of Administration, Application, Distribution Channel.


The product segment in the corticosteroids market refers to the different types of corticosteroid drugs available. These products can vary in terms of their chemical composition, potency, and formulation. Some common corticosteroid products include prednisone, dexamethasone, hydrocortisone, and methylprednisolone. Each product may have specific indications and dosing recommendations, and healthcare providers may choose a particular corticosteroid product based on the patient's condition and individual response.

Route of Administration:

The route of administration segment in the corticosteroids market pertains to how the corticosteroid drugs are delivered into the body. Corticosteroids can be administered via various routes, including oral, injectable, topical, inhaled, and intranasal. The choice of administration route can impact the onset of action, bioavailability, and systemic side effects of corticosteroid therapy. For example, oral corticosteroids may be preferred for systemic anti-inflammatory effects, while inhaled corticosteroids may be used to target the airways in patients with asthma or chronic obstructive pulmonary disease.


The application segment in the corticosteroids market encompasses the diverse therapeutic uses of corticosteroid drugs. Corticosteroids are widely utilized for their potent anti-inflammatory and immunosuppressive properties, and they are indicated for a range of medical conditions, including asthma, allergic reactions, autoimmune disorders, skin conditions, and musculoskeletal disorders. Additionally, corticosteroids are employed in oncology for their antiemetic effects and as part of chemotherapy regimens.

Distribution Channel:

The distribution channel segment in the corticosteroids market refers to the various pathways through which corticosteroid drugs are distributed to end-users, such as hospitals, retail pharmacies, e-commerce platforms, and specialty clinics. The choice of distribution channel can have implications for factors such as product accessibility, convenience, and cost. Hospital settings may primarily dispense corticosteroids for inpatient care, while retail pharmacies and e-commerce platforms frequently serve as sources for outpatient prescriptions and over-the-counter corticosteroid products.

Get more details on this report -

Competitive Landscape:

The competitive landscape of the Corticosteroids Market is highly competitive, with a number of key players vying for market share. The market is characterized by intense competition, technological advancements, and ongoing research and development activities. The major players are focusing on strategic collaborations, partnerships, and mergers and acquisitions to expand their product portfolios and strengthen their market presence. The key factors driving the competitive landscape of the Corticosteroids Market include the increasing prevalence of various inflammatory and autoimmune diseases, rising demand for advanced treatment options, and the growing adoption of corticosteroids in the management of several medical conditions.

Top Market Players:

1. Pfizer Inc.

2. Merck & Co. Inc.

3. Novartis AG

4. GlaxoSmithKline plc

5. Sanofi

6. AstraZeneca

7. Johnson & Johnson

8. AbbVie Inc.

9. Bayer AG

10. Bristol-Myers Squibb Company

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Corticosteroids Market Size & Share, By Product (G...

RD Code : 24